These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 16095573
1. The pre-ischaemic neuroprotective effects of N1-dansyl-spermine in a transient focal cerebral ischaemia model in mice. Li J, Henman MC, Tatlisumak T, Shaw GG, Doyle KM. Brain Res; 2005 Sep 07; 1055(1-2):180-5. PubMed ID: 16095573 [Abstract] [Full Text] [Related]
2. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice. Li J, Henman MC, Doyle KM, Strbian D, Kirby BP, Tatlisumak T, Shaw GG. Brain Res; 2004 Dec 10; 1029(1):84-92. PubMed ID: 15533319 [Abstract] [Full Text] [Related]
3. The pre-ischaemic neuroprotective effects of the polyamine analogues BU43b and BU36b in permanent and transient focal cerebral ischaemia models in mice. Li J, Henman MC, Atkinson J, Fixon-Owoo S, Tatlisumak T, Shaw GG, Doyle KM. Brain Res; 2006 Mar 03; 1076(1):209-15. PubMed ID: 16473330 [Abstract] [Full Text] [Related]
4. The neuroprotective effects of N1-dansyl-spermine in the gerbil model of cerebral ischaemia. Kirby BP, Shaw GG. Brain Res; 2004 Jun 11; 1011(1):74-83. PubMed ID: 15140646 [Abstract] [Full Text] [Related]
5. Multimodal assessment of neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia. Moyanova SG, Kortenska LV, Mitreva RG, Pashova VD, Ngomba RT, Nicoletti F. Brain Res; 2007 Jun 11; 1153():58-67. PubMed ID: 17466282 [Abstract] [Full Text] [Related]
6. N1-dansyl-spermine: a potent polyamine antagonist. Kirby BP, Ryder SA, Seiler N, Renault J, Shaw GG. Brain Res; 2004 Jun 11; 1011(1):69-73. PubMed ID: 15140645 [Abstract] [Full Text] [Related]
7. Effect of spermine and N1-dansyl-spermine on epileptiform activity in mouse cortical slices. Kirby BP, Shaw GG. Eur J Pharmacol; 2005 Nov 07; 524(1-3):53-9. PubMed ID: 16253230 [Abstract] [Full Text] [Related]
8. Experimental stroke: ischaemic lesion volume and oedema formation differ among rat strains (a comparison between Wistar and Sprague-Dawley rats using MRI). Walberer M, Stolz E, Müller C, Friedrich C, Rottger C, Blaes F, Kaps M, Fisher M, Bachmann G, Gerriets T. Lab Anim; 2006 Jan 07; 40(1):1-8. PubMed ID: 16460584 [Abstract] [Full Text] [Related]
9. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia. Dawson DA, Graham DI, McCulloch J, Macrae IM. Br J Pharmacol; 1994 Sep 07; 113(1):247-53. PubMed ID: 7529111 [Abstract] [Full Text] [Related]
10. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid. Khansari PS, Halliwell RF. Neurochem Int; 2009 Dec 07; 55(7):683-8. PubMed ID: 19563851 [Abstract] [Full Text] [Related]
11. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC. Exp Neurol; 2008 Jul 07; 212(1):53-62. PubMed ID: 18462720 [Abstract] [Full Text] [Related]
12. Neuroprotective effect of gamma-glutamylethylamide (theanine) on cerebral infarction in mice. Egashira N, Hayakawa K, Mishima K, Kimura H, Iwasaki K, Fujiwara M. Neurosci Lett; 2004 Jun 03; 363(1):58-61. PubMed ID: 15157996 [Abstract] [Full Text] [Related]
13. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia. Vakili A, Hosseinzadeh F, Sadogh T. Brain Res; 2007 Sep 19; 1170():97-102. PubMed ID: 17698046 [Abstract] [Full Text] [Related]
14. Neuroprotection by oxygen in acute transient focal cerebral ischemia is dose dependent and shows superiority of hyperbaric oxygenation. Eschenfelder CC, Krug R, Yusofi AF, Meyne JK, Herdegen T, Koch A, Zhao Y, Carl UM, Deuschl G. Cerebrovasc Dis; 2008 Sep 19; 25(3):193-201. PubMed ID: 18212507 [Abstract] [Full Text] [Related]
15. New evidence of neuroprotection by lactate after transient focal cerebral ischaemia: extended benefit after intracerebroventricular injection and efficacy of intravenous administration. Berthet C, Castillo X, Magistretti PJ, Hirt L. Cerebrovasc Dis; 2012 Sep 19; 34(5-6):329-35. PubMed ID: 23154656 [Abstract] [Full Text] [Related]
16. Pattern of time-dependent reduction of histologically determined infarct volume after focal ischaemia in mice. Henrich-Noack P, Baldauf K, Reiser G, Reymann KG. Neurosci Lett; 2008 Feb 20; 432(2):141-5. PubMed ID: 18222610 [Abstract] [Full Text] [Related]
17. Neuroprotective effect of taurine against focal cerebral ischemia in rats possibly mediated by activation of both GABAA and glycine receptors. Wang GH, Jiang ZL, Fan XJ, Zhang L, Li X, Ke KF. Neuropharmacology; 2007 Apr 20; 52(5):1199-209. PubMed ID: 17386936 [Abstract] [Full Text] [Related]
18. Effect of aminoguanidine on post-ischemic damage in rodent model of stroke. Vakili A, Zahedi-Khorasani M. Pak J Pharm Sci; 2008 Jan 20; 21(1):24-8. PubMed ID: 18166515 [Abstract] [Full Text] [Related]
19. Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia. Pignataro G, Simon RP, Xiong ZG. Brain; 2007 Jan 20; 130(Pt 1):151-8. PubMed ID: 17114797 [Abstract] [Full Text] [Related]
20. The protective effect of MK-801 on infarct development over a period of 24 h as assessed by diffusion-weighted magnetic resonance imaging. Gill R, Sibson NR, Maskell L, Carpenter TA, Hall LD, Pickard JD. NMR Biomed; 1996 Sep 20; 9(6):241-8. PubMed ID: 9073302 [Abstract] [Full Text] [Related] Page: [Next] [New Search]